Provide meaningful information within minutes. Measure more regions of the brain and generate disease-targeted reports that help referring physicians get a clearer picture of neurological conditions and disease progression. Breakthrough solutions from CorTechs Labs make quantitative segmental volume reporting and assessment a routine part of your analysis—without the need for a separate 3D processing lab.
Intelligent, automated solutions from CorTechs Labs are drastically increasing the amount of volumetric imaging data available to radiologists and physicians while dramatically reducing the amount of time required to obtain an accurate analysis. NeuroQuant® is the first FDA 501(k) cleared, CE marked, Korea, Australia, and Health Canada licensed medical device software for quantitative analysis from MRI. This sophisticated, automated tool automatically segments and measures volumes of brain structures and compares these volumes to norms. LesionQuant™, the automated lesion quantification module of NeuroQuant, provides volumes and counts of new and enlarging lesions that aid physicians in disease progression monitoring and clinical treatment planning.
Obtain a more comprehensive set of brain volume information never before provided in a standard radiological read.
NeuroQuant brain volumes reports are automatically generated within your existing PACS infrastructure for review prior to incorporating into your findings.
Provide meaningful information beyond the simple ruling out of structural or lesion-based etiologies of patient complaint.
NeuroQuant procedures may be reimbursed by Medicare under CPT 76377.
We sought to compare the accuracy of a volumetric fully automated computer assessment of hippocampal volume asymmetry versus neuroradiologists’ interpretations of the temporal lobes for mesial temporal sclerosis. Detecting mesial temporal sclerosis (MTS) is important for the evaluation of patients with temporal lobe epilepsy as it often guides surgical intervention. One feature of MTS is hippocampal volume loss.